InMed Pharmaceuticals Inc.

INM · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 13 employees
220
SEC Filings
$1.33
Close 2026-09-03
13
Employees

Business Summary

InMed Pharmaceuticals is a pharmaceutical drug development company focused on proprietary small molecule drug candidates that are preferential signaling ligands of CB1 and CB2 endocannabinoid receptors. Its pipeline includes INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755 (cannabinol) cream for Epidermolysis Bullosa. Following the wind-down of subsidiary BayMedica's commercial operations in 2026, InMed's activities consist solely of preclinical drug development.

Latest Stock Quote

INM 2026-09-03 $1.33 O:$1.341 H:$1.41 L:$1.32 Vol:0.0M VWAP:$1.3328
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-20

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-09-092026-06-300001213900-26-098419EDGAR73K words
2025-09-232025-06-300001213900-25-090210EDGAR75K words
2024-09-302024-06-300001213900-24-082843EDGAR72K words
2023-09-292023-06-300001213900-23-080842EDGAR76K words
2022-09-232022-06-300001213900-22-058355EDGAR—
2021-09-242021-06-300001213900-21-049679EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310001213900-26-014996EDGAR22K words
2025-11-062025-09-300001213900-25-107152EDGAR19K words
2025-05-122025-03-310001213900-25-042126EDGAR26K words
2025-02-122024-12-310001213900-25-013063EDGAR25K words
2024-11-142024-09-300001213900-24-098445EDGAR21K words
2024-05-142024-03-310001213900-24-042467EDGAR24K words
2024-02-132023-12-310001213900-24-013414EDGAR22K words
2023-11-142023-09-300001213900-23-086255EDGAR19K words
2023-05-152023-03-310001213900-23-039477EDGAR23K words
2023-02-172022-12-310001213900-23-012859EDGAR23K words
2022-11-142022-09-300001213900-22-071487EDGAR—
2022-05-132022-03-310001213900-22-026136EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-180001213900-26-101492EDGAR2K words
2026-07-220001213900-26-080414EDGAR1K words
2026-04-030001213900-26-039943EDGAR1K words
2026-03-300001062993-26-001697EDGAR1K words
2026-03-230001062993-26-001567EDGAR1K words
2026-03-090001062993-26-001347EDGAR1K words
2026-03-060001213900-26-024752EDGAR2K words
2026-02-120001062993-26-000819EDGAR3K words
2025-12-180001062993-25-017390EDGAR1K words
2025-12-150001213900-25-121497EDGAR1K words

220 total filings indexed. 192 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

alzheimer's-disease dry-age-related-macular-degeneration epidermolysis-bullosa neurodegenerative-diseases pharmaceutical-drug-development

Company Identity

CIK0001728328
TickerINM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedA1
HeadquartersVancouver, British Columbia
Websitehttps://www.inmedpharma.com
Listed2020-11-10

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 90de3d0bb423aab5d6c341e078d4886f1e6757ffa30f45777e73514cdbb77ae6
parent: 4bdf27125a7bebbbe48b88769b3e0f044adf8c22836d476ce439c7b0955bcb24
content hash: 460a6ef97ea403acf6cd4aee30aabd0490954d7b62dd4ac40c148e5bc1d17873
signed: 2026-09-29T19:01:44.912Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up INM using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on INM, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/INM (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.